Home › Atherosclerosis › California › Torrance
Atherosclerosis clinical trials in Torrance, CA
5 studies for Atherosclerosis are looking for participants at sites in and around Torrance (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
RecruitingPhase 3
- UCLA South Bay Endocrinology, Torrance
A Phase 2b Clinical Trial of YN001 in Adults With Coronary Atherosclerosis
RecruitingPhase 2
- Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance
A Study to See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With Elevated Lp(a) Who Have Had Heart Events or Are at High Risk
RecruitingPhase 3
- Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
RecruitingPhase 3
- Research Site, Torrance
Effect of Tirzepatide on Progression of Coronary Atherosclerosis Using MDCT
RecruitingPhase 4
- Lundquist Institute for Biomedical Innovation at Harbor UCLA Medical Center (The Lundquist Institute), Torrance
About Atherosclerosis
Atherosclerosis is hardening and narrowing of the arteries caused by the buildup of a fatty substance called plaque. Learn about the risks and prevention.
More about Atherosclerosis on MedlinePlus
Atherosclerosis trials in other cities
- Boston, MA10 studies
- Houston, TX10 studies
- Washington, DC9 studies
- Arlington, VA8 studies
- Orlando, FL8 studies
- Hialeah, FL8 studies
- Durham, NC7 studies
- Memphis, TN7 studies
- Miami, FL7 studies
- Dallas, TX7 studies
- Las Vegas, NV7 studies
- Minneapolis, MN6 studies
Other studies in Torrance
- Non-Small Cell Lung Cancer11 studies
- Obesity9 studies
- Overweight9 studies
- Breast Cancer9 studies
- Bladder Cancer7 studies
- Lung Cancer7 studies
- Cardiovascular Disease7 studies
- Schizophrenia6 studies
- Heart Failure5 studies
- Metastatic Cancer4 studies
- Colorectal Cancer4 studies
- Coronary Artery Disease4 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.